尤指植物
发表于 2025-3-21 19:02:06
书目名称Chronic Lymphocytic Leukemia影响因子(影响力)<br> http://impactfactor.cn/2024/if/?ISSN=BK0226394<br><br> <br><br>书目名称Chronic Lymphocytic Leukemia影响因子(影响力)学科排名<br> http://impactfactor.cn/2024/ifr/?ISSN=BK0226394<br><br> <br><br>书目名称Chronic Lymphocytic Leukemia网络公开度<br> http://impactfactor.cn/2024/at/?ISSN=BK0226394<br><br> <br><br>书目名称Chronic Lymphocytic Leukemia网络公开度学科排名<br> http://impactfactor.cn/2024/atr/?ISSN=BK0226394<br><br> <br><br>书目名称Chronic Lymphocytic Leukemia被引频次<br> http://impactfactor.cn/2024/tc/?ISSN=BK0226394<br><br> <br><br>书目名称Chronic Lymphocytic Leukemia被引频次学科排名<br> http://impactfactor.cn/2024/tcr/?ISSN=BK0226394<br><br> <br><br>书目名称Chronic Lymphocytic Leukemia年度引用<br> http://impactfactor.cn/2024/ii/?ISSN=BK0226394<br><br> <br><br>书目名称Chronic Lymphocytic Leukemia年度引用学科排名<br> http://impactfactor.cn/2024/iir/?ISSN=BK0226394<br><br> <br><br>书目名称Chronic Lymphocytic Leukemia读者反馈<br> http://impactfactor.cn/2024/5y/?ISSN=BK0226394<br><br> <br><br>书目名称Chronic Lymphocytic Leukemia读者反馈学科排名<br> http://impactfactor.cn/2024/5yr/?ISSN=BK0226394<br><br> <br><br>
巨硕
发表于 2025-3-21 22:08:27
http://reply.papertrans.cn/23/2264/226394/226394_2.png
finite
发表于 2025-3-22 03:14:17
The Clinical Presentation of CLLedominantly a disease of the elderly with a preponderance of male patients. New evidence suggests that there are variations in gender incidence according to the clinical status of patients, with a higher male:female ratio in the groups with worse prognosis..Full blood counts and a physical examinati
仪式
发表于 2025-3-22 05:08:43
http://reply.papertrans.cn/23/2264/226394/226394_4.png
钩针织物
发表于 2025-3-22 10:59:38
Guidelines for Diagnosis, Indications for Treatment, Response Assessment, and Supportive Management road acceptance by physicians and investigators caring for patients with CLL. It is not the aim of the iwCLL guidelines to provide treatment recommendations, but definitions for the initial assessment, indication for treatment, and response assessment of CLL. Recent advances including the discovery
gruelling
发表于 2025-3-22 16:50:43
Initial Therapy of Chronic Lymphocytic Leukemiaients without very high-risk genomic alterations first-line treatment with chemoimmunotherapy is a well-examined and established standard of care. FCR is the preferred treatment in physically fit patients with mild or no comorbidities. Depending on the burden of comorbidities, less intense chemoimmu
gruelling
发表于 2025-3-22 20:01:51
http://reply.papertrans.cn/23/2264/226394/226394_7.png
Employee
发表于 2025-3-22 23:24:54
http://reply.papertrans.cn/23/2264/226394/226394_8.png
上下倒置
发表于 2025-3-23 03:14:33
Autoimmune Cytopenia in Chronic Lymphocytic Leukemiauses, patients with CLL presenting cytopenia require a careful evaluation and an individualized management. The association of CLL with cytopenias of immune origin is based on experts’ consensus, and its impact on patients’ outcome remains controversial. It is widely accepted that treatment should b
青少年
发表于 2025-3-23 08:19:11
Richter Syndromeare recognized, namely the diffuse large B-cell lymphoma (DLBCL) variant and the rare Hodgkin lymphoma (HL) variant. Histologic documentation is mandatory to diagnose RS. In the presence of clinical features suspicious of RS, diagnosis of transformation and choice of the site of biopsy may take adva